The Prognostic Value of Individual Adhesion Scores from the Revised American Fertility Society Classification System for Recurrent Endometriosis by �쑄蹂댄쁽 et al.
Yonsei Med J   http://www.eymj.org   Volume 56   Number 4   July 2015 1079
The Prognostic Value of  Individual Adhesion Scores  
from the Revised American Fertility Society Classification  
System for Recurrent Endometriosis 
Bo Hyon Yun,1,2 Young Eun Jeon,2,3 Seung Joo Chon,4 Joo Hyun Park,2,3 Seok Kyo Seo,1,2  
SiHyun Cho,2,3 Young Sik Choi,1,2 Ji Sung Lee,4 and Byung Seok Lee1,2
1Department of Obstetrics and Gynecology, Severance Hospital, Yonsei University College of Medicine, Seoul;
2Institute of Women’s Life Medical Science, Yonsei University College of Medicine, Seoul; 
3Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul;
4Department of Obstetrics and Gynecology, Gil Hospital, Graduate School of Medicine, Gachon University of Medicine and Science, Incheon, Korea.
Received: July 25, 2014
Revised: October 14, 2014
Accepted: October 14, 2014
Co-corresponding authors: Dr. Byung Seok Lee, 
Department of Obstetrics and Gynecology, 
Severance Hospital, Yonsei University College 
of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, 
Seoul 120-752, Korea.
Tel: 82-2-2228-2230, Fax: 82-2-313-8357
E-mail: dr222@yuhs.ac and
Dr. Ji Sung Lee, 
Department of Obstetrics and Gynecology, 
Gil Hospital, Graduate School of Medicine, 
Gachon University of Medicine and Science, 
21 Namdong-daero 774beon-gil, Namdong-gu, 
Incheon 405-760, Korea.
Tel: 82-32-2019-3435, Fax: 82-32-3462-8209
E-mail: dongwook@gilhospital.com
∙ The authors have no financial conflicts of 
interest.
© Copyright:
Yonsei University College of Medicine 2015
This is an Open Access article distributed under the 
terms of the Creative Commons Attribution Non-
Commercial License (http://creativecommons.org/ 
licenses/by-nc/3.0) which permits unrestricted non-
commercial use, distribution, and reproduction in any 
medium, provided the original work is properly cited.
Purpose: This study aimed to evaluate the prognostic value of each component of 
the revised American Fertility Society (rAFS) classification system for the first re-
currence of endometriosis after conservative laparoscopy. Materials and Meth-
ods: As this was a retrospective cohort study, data were collected by reviewing 
medical records. A total of 379 women ages 18 to 49 years were included. Women 
who underwent conservative laparoscopy with histologic confirmation of endome-
triosis at Gangnam Severance Hospital between March 2003 and May 2010 were 
included. Individual components of the rAFS classification system as well as preop-
erative serum CA-125 levels were retrospectively analyzed to assess their prognos-
tic values for recurrence of endometriosis. Results: Of 379 patients, 80 (21.2%) 
were found to have recurrence of endometriosis. The median duration of follow-up 
was 19.0 months, and the mean age at the time of surgery was 31.8±6.7 years. In 
endometriosis of advanced stage, younger age at the time of surgery, bilateral ovari-
an cysts at the time of diagnosis, a rAFS ovarian adhesion score >24, and complete 
cul-de-sac obliteration were independent risk factors of poor outcomes, and a rAFS 
ovarian adhesion score >24 had the highest risk of recurrence [hazard ratio=2.948 
(95% CI: 1.116‒7.789), p=0.029]. Conclusion: Our results suggest that of the 
rAFS adnexal adhesion scores, the ovarian adhesion score rather than the tubal ad-
hesion score was associated with a significantly increased risk of recurrent endome-
triosis. The preoperative serum CA-125 level may be also a significant prognostic 
factor for recurrence, as known. However, it seemed to only have borderline signifi-
cance in affecting recurrence in the current study.
Key Words:   Endometriosis, recurrence, prognostic factor, rAFS classification, 
ovarian adhesion
INTRODUCTION
Endometriosis is a common benign gynecologic disease defined by the presence of 
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the uterus and at least one ovary intact. Exclusion criteria in-
cluded previous medical or surgical treatment of endometri-
osis, previous pelvic surgery for uterine or ovarian masses, 
extrapelvic endometriosis, such as vaginal, abdominal wall, 
or pulmonary endometriosis, and malignancy. Conservative 
laparoscopy was performed by three gynecologic laparosco-
py specialists. All surgical procedures aimed for complete 
removal of all gross lesions and anatomical restoration to 
preserve or restore reproductive function; additionally, the 
procedure included electrofulguration or excision of endo-
metriotic implants on the peritoneum, excision of endome-
triomas, and lysis of adhesions. The type of surgery was 
chosen and tailored for each individual case, with consider-
ation for the severity of the disease. Postoperative medica-
tions included gonadotropin-releasing hormone agonists 
(GnRHa) and/or hormone therapy such as oral contracep-
tives, oral progestins, and a levonorgestrel-intrauterine sys-
tem. After surgery, pelvic ultrasonography was performed 
every 6‒12 months. The recurrence of endometriosis was 
defined as the recurrence of dysmenorrhea as pain recurring 
after surgery with a severity score equal to or higher than 
that before surgery or the recurrence of endometriomas with 
the presence of ovarian cysts 2 cm in diameter for more than 
two consecutive menstrual cycles.4,5,9,11
Clinical characteristics and operative findings were record-
ed for all study subjects including age at the time of surgery, 
body mass index, age at menarche, parity, menstrual history, 
coexisting adenomyosis, type of surgery, postoperative med-
ications, pregnancy after surgery, the preoperative serum 
CA-125 level, the size of the largest cyst, anatomical loca-
tion, rAFS stage, and rAFS score. The severity of endometri-
osis was determined by scores derived from the rAFS classi-
fication system10 according to operative findings including 
the location, size, extent, depth, and density of the endometri-
oma and adhesions. These rAFS component scores included 
a spot score, an ovarian cyst score, an ovarian and tubal ad-
hesion score, the bilaterality of ovarian cysts and ovarian and 
tubal adhesions, and cul-de-sac (CDS) obliteration. The 
scores were assigned by the gynecologist who performed 
the surgery. Serum CA-125 was checked after the initial di-
agnosis, up to 2 weeks prior to surgery. The level of serum 
CA-125 was measured with a CA-125 II electrochemilumi-
nescence immunoassay using the Roche/Hitachi Modular 
Analytics E170 (Roche Diagnostics, Tokyo, Japan). 
Continuous data are presented as means±standard devia-
tions or medians and interquartile ranges. Categorical data 
are presented as numbers and percentages. To compare vari-
endometrial glands and stroma outside of the uterus.1,2 The 
disease typically affects women of reproductive age and re-
mains a major cause of disability stemming from dysmenor-
rhea, chronic pelvic pain, and subfertility.1 Surgery is a con-
firmed option for relieving pain and also may improve 
fertility; since recent years, it has been performed by lapa-
roscopy with results equivalent to or better than surgery by 
laparotomy.3 However, the postoperative recurrence rates af-
ter 3 years range from 15‒30%,3 with half of these patients 
requiring reoperation.4
Recurrence of endometriosis leads to several concerns in 
women of reproductive age in terms of lowered quality of 
life caused by recurrent pain and a compromised ovarian re-
serve due to recurrent endometriomas; such issues may 
cause the clinician to hesitate when deciding the treatment 
modality. As is well known, a longer postoperative treat-
ment of endometriosis results in less recurrence. However, 
there are no definite prognostic factors for recurrence that 
can be used in the clinical field during the follow-up period, 
although many studies have been conducted to identify the 
risk factors for recurrence of endometriosis.5-9
The revised American Fertility Society (rAFS) classifica-
tion system is the most widely-used method of determining 
the severity of endometriosis by point scoring followed by 
staging. Almost all studies that have utilized the rAFS clas-
sification system have addressed the use of rAFS stage and 
score as risk factors; however, few studies have evaluated 
the predictive value of each separate component of the sys-
tem.10 In the present study, we aimed to investigate the risk 
factors of recurrent endometriosis by evaluating components 
of rAFS system from previous surgeries. 
MATERIALS AND METHODS
We retrospectively reviewed the medical records of women 
ages 18 to 49 years who underwent conservative laparosco-
py with histologic confirmation of endometriosis at Gang-
nam Severance Hospital from March 2003 to May 2010. 
The participants provided written informed consent to par-
ticipate in this study, and we received the data in an anony-
mized form. This study was carried out in accordance with 
the ethical standards of the Helsinki Declaration and was ap-
proved by the Institutional Review Board of Gangnam Sev-
erance Hospital (3-2011-0282).
Conservative laparoscopy was defined as laparoscopic 
surgical removal of all endometriotic lesions while leaving 
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whom 80 (21.2%) had recurrent endometriosis after laparo-
scopic surgery. The median duration of follow-up was 19.0 
months. The clinical characteristics of patients with and 
without recurrence of endometriosis are presented in Table 
1. Significant differences were found between the two 
groups with respect to age at the time of surgery, parity, the 
type of surgery performed, and preoperative CA-125 level. 
Table 2 shows operative findings including data for the 
rAFS classification system components for both groups. In 
addition to the rAFS total score and stage, the size of the 
largest cyst, the rAFS cyst score, the rAFS adnexal adhesion 
score, the rAFS ovarian adhesion score, and the rAFS tubal 
adhesion score were significantly higher in the recurrent en-
dometriosis group than in the non-recurrent group. There 
were also significant differences between the two groups in 
terms of the anatomical location of the cysts, the bilaterality 
of the cysts, and the bilaterality of the adnexal adhesions. Of 
the adnexal adhesions, only the frequency of bilateral ovari-
an adhesions showed a significant difference between gro-
ups, while bilateral tubal adhesions did not. The frequencies 
of no, partial, and complete CDS obliteration were 36.3%, 
27.4%, and 36.3% in the recurrent endometriosis group and 
45.2%, 36.4%, and 18.4% in the non-recurrent group, re-
ables between the recurrent and non-recurrent groups, two-
sample t-tests were used for continuous variables, and chi-
square or Fisher’s exact tests were used for categorical var-
iables where appropriate. A Kaplan-Meier survival analysis 
was used to determine the univariate relationship of the 
rAFS ovarian adhesion scores to disease-free survival times. 
Log-rank tests were used to examine significant differences 
in hazard distributions between groups according to rAFS 
ovarian adhesion scores. A Cox multivariate analysis was 
performed to eliminate confounding factors and to identify 
significant variables that could independently contribute to 
the recurrence of endometriosis. A multivariate model was 
built using factors that had p-values<0.05 on univariate anal-
ysis and excluding factors that potentially had either multi-
collinearity or clinical correlation. For all analyses, a p-val-
ue<0.05 was considered to be statistically significant. All 
statistical analyses were conducted using SPSS software 
version 18.0 (SPSS Inc., Chicago, IL, USA). 
RESULTS
The medical records of 379 patients were reviewed, of 
Table 1. Clinical Characteristics of Participants
Variables
Descriptive statistics Univariate analysis
Recurrent 
(n=80)
Non-recurrent 
(n=299)
p value 
Hazard ratio 
(95% CI)
p value
Duration of follow-up (months)   27.21±16.87   25.02±21.88 0.041
Age at time of surgery (yrs) 28.78±5.51 32.51±6.99 <0.0001 0.926 (0.893‒0.959) <0.0001
Parity (%) 0.006
0 (ref) 66 (82.5) 194 (64.9) 1
1   9 (11.3)   46 (15.4) 0.518 (0.258‒1.040) 0.064
≥2 5 (6.3)   59 (19.7) 0.256 (0.103‒0.636) 0.003
Type of surgery (%) 0.011
Laparoscopic electrocauterization  
  only (ref)
7 (8.8)   6 (2.0) 1
Laparoscopic cystectomy 64 (80.0) 242 (80.9) 0.576 (0.263‒1.262) 0.168
Laparoscopic oophorectomy   9 (11.3)   51 (17.1) 0.318 (0.118‒0.855) 0.023
Postoperative medication (%) 0.071
None 13 (16.3)   58 (19.4) 0.721 (0.387‒1.345) 0.304
GnRHa only (ref) 43 (53.8) 114 (38.1) 1
GnRHa with subsequent hormone  
  therapy
22 (27.5) 106 (35.5) 0.398 (0.238‒0.666) <0.0001
Hormone therapy only 2 (2.5) 21 (7.0) 0.397 (0.096‒1.645) 0.203
Preoperative serum CA-125 (U/mL) (%) 0.002
≤35 (ref) 12 (16.2) 100 (35.2) 1
>35 62 (83.8) 184 (64.8) 2.375 (1.279‒4.407) 0.006
GnRHa, gonadotropin-releasing hormone agonist; CI, confidence interval.
Data are expressed as mean±SD, or number of cases (%). Two sample t-test, chi-square test.
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endometriosis group (48.8%) experienced recurrent pelvic 
pain. Patients with recurrent bilateral lesions had a higher in-
cidence of bilateral cysts prior to surgery than those with 
unilateral or spot lesions (p=0.002) (Table 3). 
Univariate analyses using Cox regression for the recur-
rence of endometriosis were performed on factors that 
showed significant differences between the two groups. The 
hazard ratios (HRs) for the factors used in the univariate 
spectively, showing an increased frequency of complete 
obliteration in patients with recurrence. The rAFS spot score 
and the frequency of bilateral tubal adhesions were not dif-
ferent between the two groups. 
Of the 80 patients who experienced recurrence, 3 (3.8%) 
were diagnosed due to recurrent pain symptoms, 47 (58.7%) 
by ultrasonography, and the remaining 30 (37.5%) by surgi-
cal confirmation. About half of the patients in the recurrent 
Table 2. Operative Findings in Patients with and without Recurrence of Endometriosis
Variables
Descriptive statistics Univariate analysis
Recurrent 
(n=80)
Non-recurrent 
(n=299)
p value 
Hazard ratio 
(95% CI)
p value
Size of the largest cyst (cm) 5.53±2.58   4.88±2.42  0.038 1.102 (1.021‒1.188)  0.012
Anatomical location of cyst (%)  0.001
Spot only 2 (2.5)   4 (1.3) 1
Left-sided unilateral 20 (25.0) 121 (40.5) 0.382 (0.144‒1.013)  0.053
Right-sided unilateral 20 (25.0)   99 (33.1) 0.597 (0.227‒1.573)  0.297
Bilateral 38 (47.5)   75 (25.1) 0.507 (0.186‒1.380)  0.184
rAFS stage (%) <0.0001
I 0 (0)   2 (0.7) 1
II 1 (1.3)   5 (1.7)
III 26 (32.5) 175 (58.5) 0.631  0.649
IV 59 (66.3) 117 (39.1)
rAFS total score 58.89±30.07   43.91±26.35 <0.0001 1.014 (1.007‒1.022) <0.0001
rAFS spot score 0.68±1.27   0.84±1.47  0.362
rAFS ovarian cyst score 25.95±10.05 22.54±8.29  0.006 1.027 (1.004‒1.051)  0.023
Ovarian cyst bilaterality (%) <0.0001
Unilateral 38 (48.7) 196 (70.8) 1
Bilateral 40 (51.3)   81 (29.2) 1.955 (1.253‒3.053)  0.003
rAFS adnexal adhesion score 17.06±16.05   11.97±12.97  0.003 1.017 (1.003‒1.031)  0.014
Adnexal adhesion bilaterality (%)  0.004
No adhesion 10 (12.5)   70 (23.4) 1
Unilateral 26 (32.5) 123 (41.1) 1.472 (0.705‒3.071)  0.303
Bilateral 44 (55.0) 106 (35.5) 2.225 (1.116‒4.436)  0.023
rAFS ovarian adhesion score 9.94±8.76   6.90±7.26  0.002 1.038 (1.012‒1.065)  0.004
Ovarian adhesion bilaterality (%)  0.002
No adhesion 11 (13.8)   78 (26.1) 1
Unilateral 26 (32.5) 122 (40.8) 1.466 (0.721‒2.978)  0.291
Bilateral 43 (53.8)   99 (33.1) 2.341 (1.204‒4.549)  0.012
rAFS tubal adhesion score 7.23±8.95   5.08±6.89  0.049 1.024 (0.998‒1.050)  0.072
Tubal adhesion bilaterality (%)  0.288
No adhesion 33 (41.3) 132 (44.1)
Unilateral 19 (23.8)   88 (29.4)
Bilateral 28 (35.0)   79 (26.4)
CDS obliteration (%)  0.003
None 29 (36.3) 135 (45.2) 1
Partial 22 (27.4) 109 (36.4)
Complete 29 (36.3)   55 (18.4) 2.182 (1.383‒3.443)  0.001
rAFS, revised American Fertility Society; CDS, cul-de-sac; CI, confidence interval.
Data are expressed as mean±SD, or number of cases (%). Two sample t-test, chi-square test.
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bilateral ovarian adhesions (p=0.012), and complete CDS 
obliteration (p=0.001) were all shown to be factors that may 
influence the risk for recurrent endometriosis. 
Fig. 1 show the Kaplan-Meier survival curves for progres-
sion-free survival for different rAFS ovarian adhesion score 
groups. Given that the rAFS ovarian adhesion score classi-
fies each subject into a specific category, subjects were 
placed into four groups that were determined by scores of 
0‒8, 9‒16, 17‒24, and >24, and those with higher scores 
were associated with an increased hazard of recurrence (p= 
0.004). Patients with a rAFS ovarian adhesion score of >24 
had a significantly higher cumulative hazard of recurrence 
compared with those having a score of ≤24 (p=0.004).
A multivariate Cox regression analysis revealed that a 
rAFS ovarian adhesion score of >24 was associated with a 
significantly increased risk of recurrence of endometriosis 
(Table 4). The variables that we identified as independent 
risk factors for the recurrence of endometriosis were young-
er age at the time of surgery, ovarian cyst bilaterality, rAFS 
ovarian adhesion score >24, and complete CDS obliteration. 
A rAFS ovarian score of >24 was the risk factor with the 
highest (HR: 2.996; 95% CI: 1.133‒7.923; p=0.027), and 
the HR for complete CDS obliteration was the second high-
est (HR: 2.274; 95% CI: 1.227‒4.215; p=0.009). Although 
not as high, the HR for bilateral ovarian cysts indicated a 
significantly increased risk of recurrence (HR: 1.835; 95% 
CI: 1.137‒2.960; p=0.013). In addition, a postoperative med-
ication regimen of GnRHa with subsequent hormone therapy 
indicated a decreased risk of recurrence compared with Gn-
RHa alone.
analyses are presented in Table 1 and 2, beside the descrip-
tive statistics. Age at the time of surgery (p<0.0001), parity 
(nulliparous versus≥2; p=0.003), type of surgery (electro-
cauterization only versus oophorectomy; p=0.023), postop-
erative medications (GnRHa only versus GnRHa with sub-
sequent hormone therapy; p<0.0001), preoperative serum 
CA-125 level >35 U/mL (p=0.006), size of the largest cyst 
(p=0.012), rAFS total score (p<0.0001), rAFS ovarian cyst 
score (p= 0.023), ovarian cyst bilaterality (unilateral versus 
bilateral; p=0.003), rAFS ovarian adhesion score (p=0.004), 
Table 3. Characteristics of Patients with Recurrence of En-
dometriosis
Variables
Number 
(proportion)
Recurrent pain (%)        39 (48.8)
Diagnostic tool for recurrence (%)
Symptoms only        3 (3.8)
Ultrasonography only        47 (58.7)
Surgical confirmation        30 (37.5)
Recurrent cyst bilaterality (%)
Only spot        5 (6.3)
Unilateral
Left side        30 (37.5)
Right side        26 (32.5)
Bilateral        19 (23.8)
Ratio of initial bilateral cyst to recurrent  
  lesion (%), p=0.002*
Recurrent spot 0 /4 (0)
Recurrent unilateral   25/57 (43.9)
Recurrent bilateral   15/19 (78.9)
*Chi-square test.
Fig. 1. Cumulative incidence of recurrent endometriosis for different ovarian adhesion score groups. (A) Patients divided into four groups. (B) Groups with a 
cut off level of 24.
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trating endometriosis (DIE). This is further complicated by 
the anatomical location of the lesions, given that they are 
found just above the ureter. In patients with endometriosis, 
the more complete the removal of the lesions, the lower the 
rate of recurrence.12 As a result, dense ovarian adhesions and 
pelvic-side-wall DIE are associated with a poor prognosis of 
the recurrence of endometriosis. Our results show that the 
ovarian adhesion score, rather than the tubal adhesion score, 
correlated with the recurrence of endometriosis. Several pre-
vious studies have examined the relationship between ad-
nexal adhesions and clinical outcomes of endometriosis in 
terms of infertility.13 However, these studies were focused 
on tubal rather than ovarian adhesions. The difference ob-
served in our study offers evidence that tubal involvement 
may affect infertility due to its distortion of the anatomy and 
micromovement of fimbriae, while endometriomas involv-
ing the ovaries may be more related to recurrence. 
In our study, the preoperative serum CA-125 level was a 
predictive factor for the recurrence of endometriosis with 
borderline significance (p=0.084), although it was signifi-
cantly correlated with the rAFS total score, ovarian cyst 
score, and complete CDS obliteration excluding adhesion. 
Serum CA-125 is currently the most useful marker of endo-
metriosis and is typically checked preoperatively to evaluate 
the usefulness of postoperative monitoring. Preoperative 
CA-125 may have limited diagnostic accuracy, however, 
with low sensitivity and thus limited adequacy for predicting 
recurrence of endometriosis. We calculated the area under 
the receiver operating curve for preoperative CA-125 lev-
els; however, our results did not provide an adequate level 
of discrimination or sensitivity (data not shown). As several 
studies have shown that preoperative CA-125 in conjunc-
tion with other markers may have considerable overall sen-
sitivity and specificity,14,15 further studies that involve a larg-
er number of participants and combine preoperative serum 
CA-125 levels with rAFS scores from surgery may provide 
meaningful findings. 
Previously, several studies have suggested that neither the 
rAFS classification system nor the stage correlates with post-
operative outcomes such as pregnancy, recurrence of dys-
menorrhea, and recurrence of the disease.8,9 Although these 
previous studies compared the rAFS stage itself, we ana-
lyzed not only the stage but also the detailed components of 
the classification. Meanwhile, our results indirectly share the 
finding of a higher recurrence risk in an advanced stage,11,16 
as the combination of ovarian adhesion, bilateral ovarian 
cysts, and complete CDS obliteration reflect an advanced 
DISCUSSION
In this study, we evaluated each component of the rAFS 
classification system and demonstrated that the ovarian ad-
hesion score of the previous surgery was the best prognostic 
factor for the recurrence of endometriosis. In addition, we 
found that complete CDS obliteration and bilateral ovarian 
cysts were also significant predictors of disease recurrence. 
Along with the previous studies, our study adds to findings 
of increased recurrence in advanced-stage endometriosis, re-
flected by complete CDS obliteration and bilateral ovarian 
cysts in our study.11
Our data suggest that a threshold rAFS ovarian adhesion 
score of >24 correlates with significant disease recurrence. 
According to the rAFS classification system,10 an ovarian 
adhesion score of >24 implies the existence of dense adhe-
sions invading at least two thirds of the ovary, with subovar-
ian adhesions invading the lateral pelvic wall. In cases of 
dense subovarian adhesions, which consist of reactive fi-
brotic tissue involving the lateral pelvic peritoneum, the le-
sions are potentially deeply infiltrating, similar to deep infil-
Table 4. Hazard Ratios and p Values from Multivariate Analy-
sis of Clinical Factors
Variables
Multivariate analysis
p value Hazard ratio (95% CI)
Age at time of surgery (yrs) <0.0001 0.920 (0.885‒0.957)
Postoperative medication
None 0.559 1.236 (0.607‒2.513)
GnRHa only (ref) - 1
GnRHa with subsequent  
  hormone therapy
0.001 0.385 (0.224‒0.663)
Hormone therapy only 0.799 0.827 (0.193‒3.552)
Preoperative serum CA-125  
  level (U/mL)
≤35 (ref) - 1
>35 0.084 1.773 (0.926‒3.393)
Size of the largest cyst (cm) 0.979 1.001 (0.911‒1.100)
Ovarian cyst bilaterality
Unilateral (ref) - 1
Bilateral 0.013 1.835 (1.137‒2.960)
rAFS ovarian adhesion score
≤24 (ref) - 1
>24 0.027 2.996 (1.133‒7.923)
CDS obliteration
Non-complete (ref) - 1
Complete 0.009 2.274 (1.227‒4.215)
GnRHa, gonadotropin-releasing hormone agonist; rAFS, revised American 
Fertility Society; CDS, cul-de-sac; CI, confidence interval.
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Also, increased preoperative serum CA-125 levels seemed 
to be associated with the risk of recurrence yet showed bor-
derline significance. However, the CA-125 level still re-
mains the most commonly-used biomarker of endometrio-
sis. Thus, identification of new combinations of markers in 
addition to serum CA-125 would be more useful in predict-
ing recurrence risk. 
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